Sabordino, Baby Girl .

HRN: 25-92-90  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2024
AMPICILLIN 250MG (VIAL)
09/28/2024
10/04/2024
IV
75mg
Q12
Prematurity
Waiting Final Action 
09/28/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/28/2024
10/04/2024
IV
18mg
OD
Prematurity
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: